- CEO
- Siew Keong Ho
- Full Time Employees
- 120
- Sector
- Distribution services
- Industry
- Wholesale distributors
- Address
- 14 Kung Chong Road Singapore NE Singapore 159150
- IPO Date
- Jul 6, 2000
- Business
- Ellipsiz Ltd Ellipsiz Ltd (SGX:BIX), an investment holding company founded in 1992 and headquartered in Singapore, distributes manufacturing, testing, and inspection equipment to the semiconductor, electronics manufacturing, and telecommunication industries; provides customized automated precision systems for test automation, high-precision fiber and lens assembly, and wafer-level testing; develops properties for investment; and produces and distributes fresh eggs. The company operates through Distribution and Services Solutions, which offers wafer fabrication equipment including lithography tools, wet benches, coater/developers, abatement systems, board-level test systems for in-circuit and functional testing, optical and X-ray inspection, scientific instruments, electronic equipment, consumables, technical support services, and fab support such as turnkey facilities hook-up, specialty chemicals, and relocation; Automated Precision System Solutions for specialized automation; Property Investment and Development; and Egg Production and Distribution segments. Ellipsiz Ltd serves customers in semiconductor, electronics manufacturing, aerospace, oil and gas, hospitals, pharmaceutical, and food processing sectors across Singapore, Malaysia, China, Taiwan, Indonesia, and internationally, functioning as a subsidiary of Bevrian Pte. Ltd. In recent developments, the company sold its entire 51% stake in Axis-Tec Pte Ltd to Shenzhen Yanmade Technology Inc. for SGD 2.94 million in December 2024; divested SV Probe Pte. Ltd. to NIDEC-READ Corporation in early 2024; acquired shares for on-market buyback totaling SGD 116,000 during FY2024; and advanced egg farm initiatives through an 80% interest in ISE Capital Management Pte Ltd, which holds 70% of ISE Foods Holdings Pte Ltd for Singapore's fourth egg farm project while pursuing biosecurity funding and expansions in Southeast Asia. FY2024 revenue reached $55.1 million amid business development with Chinese equipment suppliers and vending solutions.